Related Experiment Videos
New strategies for antibacterial drug design
1SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (South), Harlow, Essex, UK. david_j_knowles@sbphrd.com
Trends in Microbiology
|November 14, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Measurement of time-dependent CP asymmetries in B0-->D(*)+/-pi-/+ decays and constraints on sin(2beta+gamma).
Physical review letters·2004
Limits on the decay-rate difference of neutral B mesons and on CP, T, and CPT violation in B(0-0)B oscillations.
Physical review letters·2004
Measurement of the branching fractions and CP asymmetry of B--->D(0)((CP))K- decays with the BABAR detector.
Physical review letters·2004
Tripartite toxin-antitoxin systems: expanding the paradigm of molecular interplay and antiphage defense.
Trends in microbiology·2026
Shiny metal catalysts at the origin of metabolism.
Trends in microbiology·2026
The meta-holobiont: rethinking marine species interactions through microbial connectivity.
Trends in microbiology·2026
The narrowing prokaryote-eukaryote divide reveals a complexity spectrum.
Trends in microbiology·2026
Coarse-grained resource allocation modeling for decoding and rewiring microbial metabolism.
Trends in microbiology·2026
Biological language models uncover hidden bacterial antiviral immunity repertoires.
Trends in microbiology·2026
Unlocking G4 DNA affinity through aromatic side chains: a comparative study of nickel(II), copper(II), and zinc(II) salnaphen derivatives.
Dalton transactions (Cambridge, England : 2003)·2026
Impact of adsorption-based solidification on the pharmaceutical performance and antidyslipidemic efficacy of simvastatin-ezetimibe SNEDDS.
International journal of pharmaceutics: X·2026
Mol-CADiff: text-conditional molecule generation via causality-aware autoregressive diffusion.
Nature communications·2026
Mechanistic evaluation of sulfobutylether-β-cyclodextrin complexation as a formulation strategy to enhance solubility and oral exposure of BCS Class II compounds.
International journal of pharmaceutics·2026